Ethical Issues in Genomics Research in Persons with Alzheimer's Disease/Alzheimer's Disease-related Dementia (AD/ADRD): a Systematic Review

Overview

Journal BMC Med Ethics

Publisher Biomed Central

Specialty Medical Ethics

Date 2024 Nov 26

PMID 39587628

Authors

Aminu Yakubu

Isaac Adedeji

Oluchi C Maduka

Ayodele Jegede

Clement Adebamowo

Affiliations

Soon will be listed here.

Abstract

Introduction: Given the growing number of Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) genomics research projects and the vulnerabilities of study participants, it is critical to evaluate the literature on the ethical challenges in such studies to ensure high ethical standards.

Methods: We conducted a systematic review of the literature on ethical issues in AD/ADRD genomics research. We searched Embase, PsycINFO, CiNAHL, Scopus, and Ovid Medline for empirical and normative papers published in peer-reviewed journals on the ethical issues involved in conducting genomics research among persons with AD/ADRD. We used ethical principles from an existing framework as a priori codes to categorize the ethical issues and adapted another framework of Dementia Research Ethical Issues (DREI) as subcategories for our synthesis. We used the 2021 PRISMA guidelines to guide our study.

Results: We screened 5,509 papers and included 27 of these papers in the systematic review after deduplication, title, and full-text review. The papers contained 109 ethical issues that were mapped against 42 out of 75 relevant DREIs. The highest number of DREIs were mapped to "respect for persons and communities", "favorable risk-benefit ratio", "informed consent" and "scientific validity". The least mapped principles to the DREIs were "fair participant selection", "independent review", "social value", and "collaborative partnership".

Conclusion: Our review showed that there is a dearth of literature on the ethical principles of "fair participant selection", "independent review", "social value" and "collaborative partnership" in genomics research on AD/ADRDs. It is difficult to draw firm conclusions from the distribution of attention paid to specific principles because these may only reflect the concerns of AD/ADRD genomics research ethicists in high-income countries. There is need for more research on the ethics of AD/ADRD genomics research in low and middle-income countries for a more balanced account of the important ethical considerations in this field.

References

Thorogood A, Maki-Petaja-Leinonen A, Brodaty H, Dalpe G, Gastmans C, Gauthier S . Consent recommendations for research and international data sharing involving persons with dementia. Alzheimers Dement. 2018; 14(10):1334-1343. DOI: 10.1016/j.jalz.2018.05.011. View

Mertz M, Nobile H, Kahrass H . Systematic reviews of empirical literature on bioethical topics: Results from a meta-review. Nurs Ethics. 2020; 27(4):960-978. PMC: 7323745. DOI: 10.1177/0969733020907935. View

Porteri C, Albanese E, Scerri C, Carrillo M, Snyder H, Martensson B . The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues. Neurobiol Aging. 2017; 52:132-140. DOI: 10.1016/j.neurobiolaging.2016.07.011. View

Goldberg T, Huey E, Devanand D . Association of APOE e2 genotype with Alzheimer's and non-Alzheimer's neurodegenerative pathologies. Nat Commun. 2020; 11(1):4727. PMC: 7501268. DOI: 10.1038/s41467-020-18198-x. View

Strech D, Synofzik M, Marckmann G . Systematic reviews of empirical bioethics. J Med Ethics. 2008; 34(6):472-7. DOI: 10.1136/jme.2007.021709. View

Torke A, Alexander G, Lantos J . Substituted judgment: the limitations of autonomy in surrogate decision making. J Gen Intern Med. 2008; 23(9):1514-7. PMC: 2518005. DOI: 10.1007/s11606-008-0688-8. View

Birchley G . The theorisation of 'best interests' in bioethical accounts of decision-making. BMC Med Ethics. 2021; 22(1):68. PMC: 8167991. DOI: 10.1186/s12910-021-00636-0. View

Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N . New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54(4):412-436. PMC: 9005347. DOI: 10.1038/s41588-022-01024-z. View

Davis D . Ethical issues in Alzheimer's disease research involving human subjects. J Med Ethics. 2017; 43(12):852-856. DOI: 10.1136/medethics-2016-103392. View

10.

Wauters A, Van Hoyweghen I . Global trends on fears and concerns of genetic discrimination: a systematic literature review. J Hum Genet. 2016; 61(4):275-82. DOI: 10.1038/jhg.2015.151. View

11.

Karlawish J, Kim S, Knopman D, van Dyck C, James B, Marson D . The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment. Am J Geriatr Psychiatry. 2008; 16(3):240-7. DOI: 10.1097/JGP.0b013e318162992d. View

12.

Matshabane O, Campbell M, Faure M, Appelbaum P, Marshall P, Stein D . The role of causal knowledge in stigma considerations in African genomics research: Views of South African Xhosa people. Soc Sci Med. 2021; 277:113902. PMC: 8450780. DOI: 10.1016/j.socscimed.2021.113902. View

13.

Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

14.

Porteri C, Frisoni G . Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer's disease: how and what to tell. A kickstart to an ethical discussion. Front Aging Neurosci. 2014; 6:41. PMC: 3959740. DOI: 10.3389/fnagi.2014.00041. View

15.

Post S . Genetics, ethics, and Alzheimer disease. J Am Geriatr Soc. 1994; 42(7):782-6. DOI: 10.1111/j.1532-5415.1994.tb06542.x. View

16.

Issa A, Keyserlingk E . Current and future clinical trials for Alzheimer's disease: evolving ethical concerns. Prog Neuropsychopharmacol Biol Psychiatry. 2000; 24(8):1229-49. DOI: 10.1016/s0278-5846(00)00137-8. View

17.

Davies R, Ives J, Dunn M . A systematic review of empirical bioethics methodologies. BMC Med Ethics. 2015; 16:15. PMC: 4357052. DOI: 10.1186/s12910-015-0010-3. View

18.

van der Vorm A, Rikkert M, Vernooij-Dassen M, Dekkers W . Genetic research into Alzheimer's disease: a European focus group study on ethical issues. Int J Geriatr Psychiatry. 2007; 23(1):11-5. DOI: 10.1002/gps.1825. View

19.

Bedeker A, Nichols M, Allie T, Tamuhla T, van Heusden P, Olorunsogbon O . A framework for the promotion of ethical benefit sharing in health research. BMJ Glob Health. 2022; 7(2). PMC: 8845198. DOI: 10.1136/bmjgh-2021-008096. View

20.

Dubois M, Bravo G, Graham J, Wildeman S, Cohen C, Painter K . Comfort with proxy consent to research involving decisionally impaired older adults: do type of proxy and risk-benefit profile matter?. Int Psychogeriatr. 2011; 23(9):1479-88. DOI: 10.1017/S1041610211000433. View